Maximiliano Arce
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Vascular Biology; Research group Peetra Magnusson
- E-mail:
- max.arce@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Short presentation
I am a vascular biologist and stem cell researcher interested in Cerebral Cavernous Malformations (CCM).
We use patient-derived cells in vitro and in vivo CCM models to understand the pathogenesis of this intricate disease and to design efficient pharmacological strategies that can improve patient´s quality of life.
Publications
Recent publications
Part of Cell Reports, 2025
- DOI for KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation
- Download full text (pdf) of KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation
BMI1 Inhibition Improves Lesion Burden in Cerebral Cavernous Malformations
Part of Circulation, p. 738-741, 2024
Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 1330-1345, 2024
Part of Nature Cardiovascular Research, p. 1549-1567, 2024
- DOI for Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation
- Download full text (pdf) of Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation
Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
Part of International Journal of Molecular Sciences, 2022
- DOI for Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
- Download full text (pdf) of Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
All publications
Articles in journal
Part of Cell Reports, 2025
- DOI for KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation
- Download full text (pdf) of KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation
BMI1 Inhibition Improves Lesion Burden in Cerebral Cavernous Malformations
Part of Circulation, p. 738-741, 2024
Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 1330-1345, 2024
Part of Nature Cardiovascular Research, p. 1549-1567, 2024
- DOI for Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation
- Download full text (pdf) of Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation
Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation
Part of Blood, p. 2154-2169, 2022
- DOI for Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation
- Download full text (pdf) of Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation
Part of World Neurosurgery, 2022
Part of Stroke, p. 1418-1427, 2021
Articles, review/survey
Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
Part of International Journal of Molecular Sciences, 2022
- DOI for Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
- Download full text (pdf) of Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations